Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules

Journal of Experimental Medicine

Volumn 184, Issue 5, 1996, Pages 1747-1753

  Katz, John F ^a   Stebbins, Christopher ^a   Appella, Ettore ^b   Sant, Andrea J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FEMALE; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029853195     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.5.1747     Document Type: Article

References (44)

1. Sant, A.J., and J. Miller. 1994. MHC class II antigen processing: biology of invariant chain. Curr. Opin. Immunol. 6:57-63.
2. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell. 84:505-507.
3. Wolf, P., and H. Ploegh. 1995. How MHC molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Biol. 11:267-306.
4. Busch, R., and E. Mellins. 1996. Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:51-58.
5. Roche, P., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (Lond.). 345:615-618.
6. Teyton, L., D. O'Sullivan, P. Dickson, V. Lotteau, A. Sette, P. Fink, and P. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature (Lond.). 348:39-44.
7. Anderson, M., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA. 89:2282-2286.
8. Schaiff, T., K. Hruska, C. Bono, S. Shuman, and B. Schwartz. 1991. Invariant chain influences post-translational processing of HLA-DR molecules J. Immunol. 147:603-608.
9. Layet, C., and R. Germain. 1991. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex AαAβ dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc. Natl. Acad. Sci. USA. 88:2346-2350.
10. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S. Schmid, V. Quaranta, and P. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature (Lond.). 348:600-605.
11. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707-716.
12. Pieters, J., H. Horstmann, O. Bakke, G. Griffiths, and J. Lipp. 1991. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J. Cell Biol. 115:1213-1223.
13. Sanderson, F., M.J. Kleijmeer, A. Kelly, D. Verwoerd, A. Tulp, J.J. Neefjes, H.J. Geuze, and J. Trowsdale. 1994. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science (Wash. DC). 266:1566-1569.
14. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J.J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature (Lond.). 368:551-554.
15. Ceman, S., R.A. Rudersdorf, J.M. Petersen, and R. DeMars. 1995. DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing. J. Immunol. 154:2545-2556.
16. Fling, S.P., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature (Lond.). 368: 554-558.
17. Sloan, V.S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature (Lond.). 375: 802-806.
18. Denzin, L.K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell. 82:155-165.
19. Sherman, M.A., D.A. Weber, and P.E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 3:197-205.
20. Sanderson, F., C. Thomas, J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity. 4:87-96.
21. Chicz, R.M., R.G. Urban, J.G. Gorga, D.A.A. Vignali, W.S. Lane, and J.L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR Alleles. J. Exp. Med. 178:27-47.
22. d. Science (Wash. DC). 256:1817-1820.
23. Loss, G.E., C.E. Elias, P.E. Fields, R.K. Ribaudo, M. McKisic, and A.J. Sant. 1993. MHC class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I antigen presentation pathways. J. Exp. Med. 178: 73-85.
24. Nuchtern, J., W. Biddison, and R. Klausner. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature (Lond.). 343:74-76.
25. Bikoff, E. 1992. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous proteins antigens. J. Immunol. 149:1-8.
26. Moreno, J., D. Vignali, F. Nadimi, S. Fuchs, L. Adorini, and G. Hammerling. 1991. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J. Immunol. 147:3306-3313.
27. Bodmer, H., S. Viville, C. Benoist, and D. Mathis. 1994. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science (Wash. DC). 263: 1284-1286.
28. Sant, A.J. 1994. Endogenous antigen presentation by MHC class II molecules. Immunologic Res. 13:253-267.
29. Katz, J.F., and A.J. Sant. 1993. T cell receptor recognition of MHC class II alloantigens is highly cell type dependent. J. Immunol. 152:1629-1640.
30. Panina-Bordignon, P., G. Corridin, E. Roosnek, A. Sette, and A. Lanzavecchia. 1991. Processing of human serum proteins generates determinants recognized by class II alloreactive T cells. Science (Wash. DC). 252:1548-1550.
31. Izumi, M., H. Miyazawa, T. Kamakura, I. Yamaguch, T. Endo, and F. Hanaoka. 1991. Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. Exp. Cell. Res. 197:229-233.
32. Sant, A.J., and R.N. Germain. 1989. Intracellular competition for component chains determines class II MHC cell surface phenotype. Cell. 57:797-805.
33. Stebbins, C.C., G.E. Loss, C.G. Elias, A. Chervonsky, and A.J. Sant. 1995. The requirement for DM in class II restricted antigen presentation and SDS-stable dimer formation is allele and species dependant. J. Exp. Med. 181:223-234.
34. Sadegh-Nasseri, S., and R.N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature (Lond.). 353:167-170.
35. Dornmair, K., B. Rothenhausler, and H.M. McConnell. 1989. Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harbor Symp. Quant. Biol. 54:409-416.
36. Nelson, C., S.J. Petzold, and E.R. Unanue. 1993. Identification of two distinct properties of class II major histocompatibility complex associated peptides. Proc. Natl. Acad. Sci. USA. 90:1227-1231.
37. Mellins, E., S. Kempin, L. Smith, T. Monji, and D. Pious. 1991. A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex. J. Exp. Med. 174:1607-1615.
38. Pinet, V., M. Malnati, and E. Long. 1994. Two processing pathways for the MHC class II restricted presentation of exogenous influenza virus antigen. J. Immunol. 152:4852-4860.
39. Riberdy, J., and P. Cresswell. 1992. The antigen processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J. Immunol. 148:2586-2590.
40. k class II molecules in human APC containing deleted or mutated HLA-DM genes. J. Immunol. 153:5382-5392.
41. Sette, A., S. Ceman, R. Kubo, K. Sakaguchi, E. Appella, D. Hunt, T. Davis, H. Michel, J. Shabanowitz, R. Rudesdorf, H. Grey, and R. DeMars. 1992. Invariant chain peptides in most HLA-DR molecules of an antigen processing mutant. Science (Wash.). 258:1801-1804.
42. Riberdy, J.M., J.R. Newcomb, M.J. Surman, J.A. Barbosa, and P. Cresswell. 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (Lond.). 360:474-477.
43. Fung-Leung, W., C.D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P.A. Peterson, S.R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science (Wash. DC). 271:1278-1281.
44. Runnels, H.A., J.C. Moore, and P.E. Jensen. 1996. A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J. Exp. Med. 183:127-136.